Cargando…

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH

PURPOSE: Limited data are available regarding the role of triglycerides, cholesterol and lipoproteins ratios as risk factors for nonalcoholic fatty liver disease (NAFLD) progression. In the present study, the investigators aimed to investigate the value of cardiovascular risk ratios of triglycerides...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegazy, Mona, Saleh, Shereen A, Ezzat, Ahmed, Behiry, Mervat E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021917/ https://www.ncbi.nlm.nih.gov/pubmed/32104026 http://dx.doi.org/10.2147/DMSO.S229590

Ejemplares similares

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
por: Hegazy, Mona A, et al.
Publicado: (2019)

Novel application of the traditional lipid ratios as strong risk predictors of nonsmall-cell lung cancer risk in a Chinese population
por: Qiu, Xiaohua, et al.
Publicado: (2022)

Value of Albumin-Fibrinogen Ratio and CRP-Albumin Ratio as Predictor Marker of Disease Activity in Egyptian RA Patients, Correlated with Musculoskeletal Sonography
por: Afifi, Naglaa, et al.
Publicado: (2020)

Monocyte to eosinophil ratio as a diagnostic biomarker for overlap syndrome and predictor of disease exacerbation
por: Ali, Asmaa, et al.
Publicado: (2023)

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
por: Hegazy, Mona A, et al.
Publicado: (2020)

Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study
por: Yamany, Ahmed, et al.
Publicado: (2020)

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
por: Takayama, Fusako, et al.
Publicado: (2009)

The role of oxidized lipid species in insulin resistance and NASH in children
por: Santoro, Nicola, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE)
por: Meshaal, Marwa Sayed, et al.
Publicado: (2019)

Pro-apoptotic Bax mRNA expression: A novel predictor for systemic lupus erythematosus disease flare-up
por: Yousef, Rasha N, et al.
Publicado: (2022)

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients
por: Fayed, Ahmed, et al.
Publicado: (2018)

SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects
por: Galano, Melanie, et al.
Publicado: (2022)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Data on the existence ratio and social utility of Nash equilibria and of the Perfectly Transparent Equilibrium
por: Fourny, Ghislain, et al.
Publicado: (2020)

NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
por: Sunami, Yoshiaki
Publicado: (2020)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial
por: Nagy, Ebtesam N, et al.
Publicado: (2021)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer disease
por: Ali, Shereen K, et al.
Publicado: (2013)

The essential John Nash
por: Nash, John, et al.
Publicado: (2002)

Molecular Pathogenesis of NASH
por: Caligiuri, Alessandra, et al.
Publicado: (2016)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Impact of steatosis and inflammation definitions on the performance of NASH tests
por: Poynard, Thierry, et al.
Publicado: (2018)

Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021)

Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)
por: Cheng, Jianfeng, et al.
Publicado: (2012)

Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
por: Oniciu, Daniela Carmen, et al.
Publicado: (2018)

The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Stability and perfection of nash equilibria
por: Damme, Eric
Publicado: (1991)

Immune and inflammatory pathways in NASH
por: Ganz, Michal, et al.
Publicado: (2013)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

Dr. Thomas Nash Reed
Publicado: (1870)

Letter from Dr. Nash
por: Hart, James A.
Publicado: (1875)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

Dr. Eugene B. Nash
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_hdhas9na3d0fh0s9rh2ek2ifml